YOKNEAM ILIT, Israel, April 3, 2024 /PRNewswire/ — PixCell Healthcare, a leading supplier of impressive level-of-treatment diagnostic remedies, is happy to announce a strategic distribution partnership with Medline, incorporating to the partnership agreements with Henry Schein and Thermo Fisher Scientific signed in new months. These agreements mark a substantial milestone in PixCell Medical’s enlargement technique, as the business continues to greatly enhance accessibility to its flagship product or service, the HemoScreen stage-of-care Complete Blood Count (CBC) analyzer, throughout the United States.
Medline Industries, a well known healthcare source distributor, will engage in a important position in making sure seamless obtain to PixCell Medical’s ground breaking diagnostic technologies for healthcare facilities of all sizes. The partnership with Henry Schein, a world chief in health care solutions, will leverage the firm’s in depth distribution network to make the HemoScreen analyzer conveniently available to healthcare industry experts nationwide. Moreover, Thermo Fisher Scientific, renowned for its scientific skills and in depth merchandise choices, will contribute to broadening the attain of the HemoScreen analyzer inside the scientific study and laboratory group.
“We are thrilled to be part of forces with Henry Schein, Medline, and Thermo Fisher Scientific to deliver the HemoScreen stage-of-care CBC analyzer to health care providers and laboratories during the United States,” reported Dude Frak, CCO of PixCell Health care. “These strategic partnerships align with our dedication to advancing affected person treatment by delivering accurate and timely diagnostic solutions immediately to the issue of require.”
The HemoScreen analyzer presents immediate and precise CBC results in just minutes, empowering healthcare experts with actionable insights for timely diagnosis and cure conclusions at the issue of procedure. With its compact design and person-friendly interface, HemoScreen enhances performance and workflow optimization in many health care configurations, like clinics, emergency departments, and laboratories.
These the latest critical distribution agreements underscore PixCell Medical’s commitment to fostering strategic partnerships that generate marketplace penetration and enhance shopper reach. By means of these collaborations, PixCell Health-related continues to be focused to advancing health care shipping by building reducing-edge diagnostic technology obtainable and economical across various healthcare configurations.
About PixCell Healthcare
PixCell Clinical, an innovator of quick hematology testing alternatives at the level-of-treatment, has produced the only 5-element differential Total Blood Rely (CBC) analyzer that is Fda-cleared, CE-marked, and TGA-authorized for position-of-treatment use – the HemoScreen.
The moveable, simple-to-use system offers clinically demonstrated lab-correct readings of 20 regular blood count parameters within just five minutes, with just just one finger-prick of blood. Leveraging a patented, disposable cartridge preloaded with all required reagents, the company’s exceptional Viscoelastic Focusing technology, and AI-powered device vision, PixCell enables improved health care outcomes and client good quality of life and decreases charges for health care companies.
For more details: www.pixcell-health-related.com
Adhere to PixCell Clinical on LinkedIn and Twitter.
Media Make contact with:
PixCell Health-related
Jake Jones
[email protected]
Brand: https://mma.prnewswire.com/media/1501459/PixCell_Healthcare_Logo.jpg
Source PixCell Clinical
